Pan-cancer analysis of whole genomes ICGC-TCGA Pan-Cancer Analysis of Whole Genomes Consortium Nature 578 (7793), 82, 2020 | 1175 | 2020 |
Nuclear factor κB is a molecular target for sulforaphane-mediated anti-inflammatory mechanisms E Heiss, C Herhaus, K Klimo, H Bartsch, C Gerhäuser Journal of Biological Chemistry 276 (34), 32008-32015, 2001 | 733 | 2001 |
Glucosinolates in Brassica vegetables: The influence of the food supply chain on intake, bioavailability and human health R Verkerk, M Schreiner, A Krumbein, E Ciska, B Holst, I Rowland, ... Molecular nutrition & food research 53 (S2), S219-S219, 2009 | 660 | 2009 |
Cancer Chemopreventive Activity of Xanthohumol, a Natural Product Derived from Hop C Gerhauser, A Alt, E Heiss, A Gamal-Eldeen, K Klimo, J Knauft, ... Molecular Cancer Therapeutics 1 (11), 959-969, 2002 | 618 | 2002 |
Beer constituents as potential cancer chemopreventive agents C Gerhäuser European Journal of Cancer 41 (13), 1941-1954, 2005 | 464 | 2005 |
Mechanism-based in vitro screening of potential cancer chemopreventive agents C Gerhäuser, K Klimo, E Heiss, I Neumann, A Gamal-Eldeen, J Knauft, ... Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis 523 …, 2003 | 422 | 2003 |
Cancer chemopreventive potential of apples, apple juice, and apple components C Gerhauser Planta Med. 74 (13), 1608-1624, 2008 | 388 | 2008 |
Cancer chemopreventive potential of sulforamate, a novel analogue of sulforaphane that induces phase 2 drug-metabolizing enzymes C Gerhäuser, M You, J Liu, RM Moriarty, M Hawthorne, RG Mehta, ... Cancer Research 57 (2), 272-278, 1997 | 381 | 1997 |
Integrative genomic analyses reveal an androgen-driven somatic alteration landscape in early-onset prostate cancer J Weischenfeldt, R Simon, L Feuerbach, K Schlangen, D Weichenhan, ... Cancer cell 23 (2), 159-170, 2013 | 380 | 2013 |
Genomic deletion of PTEN is associated with tumor progression and early PSA recurrence in ERG fusion-positive and fusion-negative prostate cancer A Krohn, T Diedler, L Burkhardt, PS Mayer, C De Silva, ... The American journal of pathology 181 (2), 401-412, 2012 | 367 | 2012 |
Cancer chemopreventive activity of brassinin, a phytoalexin from cabbage RG Mehta, J Liu, A Constantinou, CF Thomas, M Hawthorne, M You, ... Carcinogenesis 16 (2), 399-404, 1995 | 289 | 1995 |
Amide analogues of trichostatin A as inhibitors of histone deacetylase and inducers of terminal cell differentiation M Jung, G Brosch, D Kölle, H Scherf, C Gerhäuser, P Loidl Journal of medicinal chemistry 42 (22), 4669-4679, 1999 | 259 | 1999 |
Intratumor DNA methylation heterogeneity reflects clonal evolution in aggressive prostate cancer D Brocks, Y Assenov, S Minner, O Bogatyrova, R Simon, C Koop, ... Cell Reports 8 (3), 798-806, 2014 | 253 | 2014 |
Cancer chemoprevention and nutri-epigenetics: state of the art and future challenges C Gerhauser Natural products in cancer prevention and therapy, 73-132, 2013 | 241 | 2013 |
DNMT and HDAC inhibitors induce cryptic transcription start sites encoded in long terminal repeats D Brocks, CR Schmidt, M Daskalakis, HS Jang, NM Shah, D Li, J Li, ... Nature genetics 49 (7), 1052-1060, 2017 | 234 | 2017 |
Inhibition of angiogenesis and endothelial cell functions are novel sulforaphane-mediated mechanisms in chemoprevention E Bertl, H Bartsch, C Gerhauser Molecular cancer therapeutics 5 (3), 575-585, 2006 | 219 | 2006 |
Quantitative comparison of DNA methylation assays for biomarker development and clinical applications. C Bock, F Halbritter, FC Carmona, S Tierling, P Datlinger, Y Assenov, ... Nature Biotechnology 34 (7), 726-737, 2016 | 214 | 2016 |
Broad spectrum antiinfective potential of xanthohumol from hop (Humulus lupulus L.) in comparison with activities of other hop constituents and xanthohumol … C Gerhäuser Molecular nutrition & food research 49 (9), 827-831, 2005 | 203 | 2005 |
Cancer chemoprevention by targeting the epigenome J Huang, C Plass, C Gerhauser Current drug targets 12 (13), 1925-1956, 2011 | 196 | 2011 |
Molecular evolution of early-onset prostate cancer identifies molecular risk markers and clinical trajectories C Gerhauser, F Favero, T Risch, R Simon, L Feuerbach, Y Assenov, ... Cancer Cell 34 (6), 996-1011. e8, 2018 | 186 | 2018 |